Immunologist speaks about unknown concerns about new gene delivery COVID19 vaccine platforms
Channel: Shirin K
Date: 27/06/2021

Meeting Date: June 14th, 2021
Witness: Dr. Shirin Kalyan - Translational Immunologist gave her testimony and critique to the House of Commons Standing Committee on Health regarding Canada's COVID-19 response. See her testimony here: https://www.youtube.com/watch?v=TEXdGVstoio

Opposition Health Critic and Member of Parliament, Don Davies, asks Dr. Kalyan three questions as a follow-up to her testimony:
1) What is her main takeaways on Canada's response to the COVID-19 pandemic?
2) What, if any, concerns she has around the new gene delivery platform COVID-19 vaccines (i.e. the mRNA vaccines [e.g. made by Pfizer and Moderna and the adenovirus vector COVID-19 vaccines  [e.g. made by Astrazeneca]) that are currently in use in Canada?
3) Should the strategy around vaccines be different based on sex and age (i.e. children and women)?